These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14505290)

  • 1. Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium.
    Shaw LJ; Raggi P; Berman DS; Callister TQ
    Prog Cardiovasc Dis; 2003; 46(2):171-84. PubMed ID: 14505290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population.
    van Kempen BJ; Ferket BS; Steyerberg EW; Max W; Myriam Hunink MG; Fleischmann KE
    Int J Cardiol; 2016 Jan; 203():422-31. PubMed ID: 26547049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of coronary calcification scanning using electron beam tomography in intermediate and high risk asymptomatic individuals.
    Rumberger JA
    J Cardiovasc Risk; 2000 Apr; 7(2):113-9. PubMed ID: 10879414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.
    van Kempen BJ; Spronk S; Koller MT; Elias-Smale SE; Fleischmann KE; Ikram MA; Krestin GP; Hofman A; Witteman JC; Hunink MG
    J Am Coll Cardiol; 2011 Oct; 58(16):1690-701. PubMed ID: 21982314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease.
    Dewey M; Hamm B
    Eur Radiol; 2007 May; 17(5):1301-9. PubMed ID: 17031453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness and future implications for cardiovascular imaging.
    Shaw LJ
    Can J Cardiol; 2013 Mar; 29(3):350-7. PubMed ID: 23332968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods.
    Rumberger JA; Behrenbeck T; Breen JF; Sheedy PF
    J Am Coll Cardiol; 1999 Feb; 33(2):453-62. PubMed ID: 9973026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Check-up" offer to managers: is screening for early recognition of disease being discredited?].
    Riemann JF
    Dtsch Med Wochenschr; 2010 Apr; 135(16):812. PubMed ID: 20391313
    [No Abstract]   [Full Text] [Related]  

  • 11. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score.
    Nasir K; Vasamreddy C; Blumenthal RS; Rumberger JA
    Int J Cardiol; 2006 Jun; 110(2):129-36. PubMed ID: 16303191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherosclerosis imaging to assess plaque progression].
    Raggi P; Bellasi A
    Ital Heart J Suppl; 2005 Aug; 6(8):481-8. PubMed ID: 16161502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
    Okubo R; Kondo M; Hoshi SL; Yamagata K
    Sleep Breath; 2015 Sep; 19(3):1081-92. PubMed ID: 25643768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study.
    Shaw LJ; Min JK; Budoff M; Gransar H; Rozanski A; Hayes SW; Friedman JD; Miranda R; Wong ND; Berman DS
    J Am Coll Cardiol; 2009 Sep; 54(14):1258-67. PubMed ID: 19778667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
    Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
    Pennell DJ; Sechtem UP; Higgins CB; Manning WJ; Pohost GM; Rademakers FE; van Rossum AC; Shaw LJ; Yucel EK; ;
    J Cardiovasc Magn Reson; 2004; 6(4):727-65. PubMed ID: 15646878
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.